Hiroaki Serizawa

Hiroaki Serizawa

Finance
Consumer Services
Health Technology

Profile

Dr. Hiroaki Serizawa is a Chief Executive Officer at AMD Therapeutics LLC.
Dr. Serizawa was previously employed as a President, Chief Executive Officer & Director by Coyote Pharmaceuticals, Inc., an Executive Director by Lifescience Catalyst Partners, Inc., an Assistant Professor by University of Kansas, a Principal by TNP Partners Corp., and a Chief Executive Officer by Tor USA, Inc.

Hiroaki Serizawa active positions

Former positions of Hiroaki Serizawa

CompaniesPositionEnd
Lifescience Catalyst Partners, Inc. Director/Board Member 2004-12-31
University of Kansas Corporate Officer/Principal 2002-12-31
Corporate Officer/Principal -
Tor USA, Inc. Chief Executive Officer -
Founder -
See the detail of Hiroaki Serizawa's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hiroaki Serizawa's experience

Connections

100 +

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies4

Finance

Health Technology

Tor USA, Inc.

Lifescience Catalyst Partners, Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. Hiroaki Serizawa